Stay updated on Dupilumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag has been updated to v3.6.3, indicating a newer build of the ClinicalTrials.gov entry. This generally reflects maintenance or bug fixes and does not alter trial data or study details.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, signaling a minor backend update. No study content or visible features were changed.SummaryDifference0.1%

- Check36 days agoChange DetectedNew navigation/help sections were added to assist users: 'No longer looking for participants', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. The treatment section label was adjusted from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision tag updated to v3.6.0 (replacing 3.5.5).SummaryDifference0.4%

- Check43 days agoChange DetectedThe revision label was updated from v3.5.4 to v3.5.5, indicating a minor metadata update to the page.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new version of the page content.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, reflecting a maintenance update to the page's software version. No study content, data, or results were modified.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.